Text Size
3806 studies found for:    Asthma: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Asthma: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)
Condition: Asthma
Intervention: Drug: Salmeterol/ fluticasone propionate
2 Not yet recruiting A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects
Condition: Asthma
Intervention: Biological: Mepolizumab
3 Completed Magnesium and Asthma - Clinical Trials
Condition: Asthma
Intervention: Drug: Magnesium
4 Suspended 4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma
Condition: Asthma
Interventions: Drug: Armstrong Albuterol Sulfate Inhalation Aerosol;   Drug: Albuterol Sulfate Inhalation Aerosol
5 Terminated
Has Results 		A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
Condition: Acute Asthma
Interventions: Drug: arformoterol (RR formoterol);   Drug: placebo;   Drug: levalbuterol
6 Recruiting Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
Condition: Asthma
Interventions: Drug: Mepolizumab;   Drug: Placebo
7 Active, not recruiting A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Condition: Asthma
Interventions: Drug: Revamilast;   Drug: Placebo
8 Completed A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise
Condition: Asthma
Interventions: Drug: Placebo;   Drug: GSK2190915
9 Recruiting Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Condition: Asthma
Interventions: Drug: Mepolizumab IV;   Drug: Mepolizumab SC;   Drug: IV placebo and SC placebo
10 Active, not recruiting
Has Results 		Asthma Intervention Research 2 (AIR2) Trial
Condition: Asthma
Intervention: Device: Alair System
11 Completed
Has Results 		Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-Week) Study-
Condition: Bronchial Asthma
Intervention: Drug: GW815SF Salmeterol/Fluticasone propionate(HFA MDI)
12 Suspended Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients
Condition: Asthma
Interventions: Drug: albuterol HFA (Armstrong's);   Drug: albuterol HFA (Proventil HFA);   Drug: HFA placebo
13 Completed
Has Results 		Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.
Condition: Asthma
Interventions: Drug: SERETIDE Rotacaps;   Drug: SERETIDE Diskus
14 Completed AZMATICS: AZithroMycin/Asthma Trial In Community Settings
Condition: Asthma
Interventions: Drug: Azithromycin;   Drug: Placebo
15 Completed TNF-Alpha Directed Therapy in Asthma
Condition: Asthma
Interventions: Drug: Study drug administration;   Procedure: Tuberculin intradermal skin test;   Procedure: Lung function test for FEV1;   Procedure: Asthma symptom scores diary;   Procedure: Quality of life diary;   Procedure: Breath nitric oxide;   Procedure: Breath condensate;   Procedure: Sputum induction;   Procedure: Blood sampling;   Procedure: Urinalysis
16 Completed A Study of Inhalation of 20,000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals
Conditions: Asthma;   Hypersensitivity
Intervention: Biological: Clinical Center Reference Endotoxin (CCRE)
17 Recruiting 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
Condition: Asthma
Interventions: Drug: ADVAIR 100/50mcg;   Drug: ADVAIR 250/50mcg;   Drug: FLOVENT 100mcg;   Drug: FLOVENT 250mcg
18 Terminated
Has Results 		Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate in Asthmatic Patients (Study P04879)(TERMINATED)
Condition: Asthma
Intervention: Drug: Mometasone Furoate
19 Completed
Has Results 		Fall Epidemic Viral Pediatric Study
Condition: Asthma
Interventions: Drug: FLOVENT™ DISKUS™ 100 mcg BID;   Drug: ADVAIR™ DISKUS™ 100/50 mcg BID
20 Recruiting An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Asthma
Condition: Asthma
Interventions: Drug: GW685698+GW642444;   Drug: Existing maintenace therepay - Inhaled Corticosteroid (ICS) alone or in combination with a long acting bronchodilator;
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years